Integrated Medical Development (IMD)

IMD exists to assist companies in integrating all existing knowledge about their compound or device, the condition it seeks to treat as well as state-of-the-art clinical research technology, regulatory and commercial environment. This integration serves as a basis for optimal planning and execution of rapid clinical development and subsequent medical and commercial success. IMD has a Consulting division that primarily provides guidance on content of medical product development plans and trial design, and a Clinical Research Organization division that helps execute medical product development plans.

IMD Management

IMD is managed by Poul Strange MD, PhD who following academia has 15 years of pharmaceutical industry experience in positions ranging from drug discovery in the laboratories through pharmacology, clinical pharmacology, clinical development, and medical affairs. Therapeutic area experience spans metabolism, cardiovascular disease, thrombosis, immunology supplemented with some oncology and neuroscience. Regulatory experience covers small molecules, biologics and devices.